Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy F Chemaly

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomingsRoy F Chemaly
Haematologica|June 22, 2019
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignanciesFareed Khawaja, Roy F Chemaly
Expert Opinion on Biological Therapy|December 10, 2008
Palivizumab: where to from here?Georgiana Georgescu, Roy F Chemaly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Reply to Jain et alFarnaz Foolad, Roy F Chemaly
Bone Marrow Transplantation|February 27, 2022
Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?Fareed Khawaja, Roy F Chemaly
BMC Infectious Diseases|January 12, 2021
Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access programHayley Gans, Roy F Chemaly
Current Opinion in Infectious Diseases|October 17, 2018
Viral therapeutics: where we are and where we are goingRoy F Chemaly, Tristan W Clark
Leukemia & Lymphoma|December 11, 2007
Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?Harrys A Torres, Roy F Chemaly
Transplantation and Cellular Therapy|May 7, 2025
Unravelling T Cell Immunity in CAR-T Therapy: Implications for Influenza VaccinationAdam G Stewart, Roy F Chemaly
Expert Opinion on Pharmacotherapy|June 12, 2010
Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adultsKaren J Vigil, Roy F Chemaly
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2021
The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomingsRoy F Chemaly
Haematologica|June 22, 2019
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignanciesFareed Khawaja, Roy F Chemaly
Expert Opinion on Biological Therapy|December 10, 2008
Palivizumab: where to from here?Georgiana Georgescu, Roy F Chemaly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Reply to Jain et alFarnaz Foolad, Roy F Chemaly
Bone Marrow Transplantation|February 27, 2022
Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?Fareed Khawaja, Roy F Chemaly
BMC Infectious Diseases|January 12, 2021
Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access programHayley Gans, Roy F Chemaly
Current Opinion in Infectious Diseases|October 17, 2018
Viral therapeutics: where we are and where we are goingRoy F Chemaly, Tristan W Clark
Leukemia & Lymphoma|December 11, 2007
Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?Harrys A Torres, Roy F Chemaly
Transplantation and Cellular Therapy|May 7, 2025
Unravelling T Cell Immunity in CAR-T Therapy: Implications for Influenza VaccinationAdam G Stewart, Roy F Chemaly
Expert Opinion on Pharmacotherapy|June 12, 2010
Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adultsKaren J Vigil, Roy F Chemaly
Pageof 26